Evidence map›Paper›PMID 28904126›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

NLRP3 and Potassium Efflux Drive Rapid IL-1β Release from Primary Human Monocytes during

Lanny Gov, Christine A Schneider, Tatiane S Lima, William Pandori, Melissa B Lodoen

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
8.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Heliyon · 2024
    Article
  12. Review
  13. Review
  14. Article
  15. Variation in CD8 T cell IFNγ differentiation to strains ofFrontiers in cellular and infection microbiology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The strategies of NLRP3 inflammasome to combatFrontiers in immunology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lanny GovDepartment of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA 92697; and Institute for Immunology, University of California, Irvine, Irvine, CA 92697.ORCID 0000-0002-9441-3628
Christine A SchneiderDepartment of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA 92697; and Institute for Immunology, University of California, Irvine, Irvine, CA 92697.
Tatiane S LimaDepartment of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA 92697; and Institute for Immunology, University of California, Irvine, Irvine, CA 92697.
William PandoriDepartment of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA 92697; and Institute for Immunology, University of California, Irvine, Irvine, CA 92697.
Melissa B LodoenDepartment of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA 92697; and Institute for Immunology, University of California, Irvine, Irvine, CA 92697 mlodoen@uci.edu.
University of California, Irvine · US

Funding

University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
Parasite dissemination in Toxoplasmic encephalitisR01AI120846 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI LODOEN, MELISSA BRUCKNER · 2016 to 2020
$2.0M
Immunology Research Training ProgramT32AI060573 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI PEARLMAN, ERIC · 2005 to 2020
$1.9M
Mechanisms of Toxoplasma gondii dissemination and transmigrationR56AI109074 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI LODOEN, MELISSA BRUCKNER · 2014 to 2014
$369k
NCATS NIH HHS UL1 TR001414NIAID NIH HHS R01 AI120846NIAID NIH HHS R56 AI109074NIAID NIH HHS T32 AI060573
6 · The paper itself

Abstract

IL-1β is produced by myeloid cells and acts as a critical mediator of host defense during infection and injury. We found that the intracellular protozoan parasite

Indexed as

Cell DifferentiationCells, CulturedFuransHeterocyclic Compounds, 4 or More RingsHumansIndenesInflammasomesInterleukin-1betaMacrophagesMonocytesNLR Family, Pyrin Domain-Containing 3 ProteinPotassiumPrimary Cell CultureProteolysisSulfonamidesSulfonesFuransHeterocyclic Compounds, 4 or More RingsIndenesInflammasomesInterleukin-1betaN-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamideNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanPotassiumSulfonamidesSulfones

Identifiers

PMID28904126
PMCPMC5648586
OpenAlexW2755321238

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.